Martin Johannes, Michaelis Marcus, Petrović Saša, Lehnen Anne-Catherine, Müllers Yannic, Wendler Petra, Möller Heiko M, Hartlieb Matthias, Glebe Ulrich
Institute of Chemistry, University of Potsdam, Karl-Liebknecht-Str. 24-25, 14476, Potsdam-Golm, Germany.
Fraunhofer Institute for Applied Polymer Research IAP, Geiselbergstr. 69, 14476, Potsdam-Golm, Germany.
Macromol Biosci. 2025 Jan;25(1):e2400316. doi: 10.1002/mabi.202400316. Epub 2024 Oct 3.
Sortase-mediated ligation (SML) has become a powerful tool for site-specific protein modification. However, sortase A (SrtA) suffers from low catalytic efficiency and mediates an equilibrium reaction. Therefore, ligations with large macromolecules may be challenging. Here, the synthesis of polymeric building blocks for sortase-mediated ligation constituting peptide-polymers with either the recognition sequence for sortase A (LPXTGX) or its nucleophilic counterpart (G) is demonstrated. The peptide-polymers are synthesized by solid-phase peptide synthesis followed by photo-iniferter (PI) reversible addition-fragmentation chain-transfer (RAFT) polymerization of various monomers. The building blocks are subsequently utilized to investigate possibilities and limitations when using macromolecules in SML. In particular, diblock copolymers are obtained even when using the orthogonal building blocks in equimolar ratio by exploiting a technique to shift the reaction equilibrium. However, ligations of two polymers can not be achieved when the degree of polymerization exceeds 100. Subsequently, C-terminal protein-polymer conjugates are synthesized. Several polymers are utilized that can replace the omnipresent polyethylene glycol (PEG) in future therapeutics. The conjugation is exemplified with a nanobody that is known for efficient neutralization of SARS-CoV-2. The study demonstrates a universal approach to polymer-LPXTGX and G-polymer building blocks and gives insight into their application in SML.
分选酶介导的连接(SML)已成为一种用于位点特异性蛋白质修饰的强大工具。然而,分选酶A(SrtA)催化效率低且介导平衡反应。因此,与大分子的连接可能具有挑战性。在此,展示了用于分选酶介导连接的聚合物构建块的合成,这些构建块构成具有分选酶A识别序列(LPXTGX)或其亲核对应物(G)的肽 - 聚合物。肽 - 聚合物通过固相肽合成,然后对各种单体进行光引发转移终止剂(PI)可逆加成 - 断裂链转移(RAFT)聚合来合成。随后利用这些构建块研究在SML中使用大分子时的可能性和局限性。特别是,通过利用一种改变反应平衡的技术,即使以等摩尔比使用正交构建块,也能获得二嵌段共聚物。然而,当聚合度超过100时,无法实现两种聚合物的连接。随后,合成了C端蛋白质 - 聚合物共轭物。使用了几种聚合物,它们可以在未来的治疗中替代无处不在的聚乙二醇(PEG)。以一种已知能有效中和SARS-CoV-2的纳米抗体为例进行了共轭。该研究展示了一种通用的聚合物 - LPXTGX和G - 聚合物构建块的方法,并深入了解了它们在SML中的应用。